The development of human papillomavirus (HPV) vaccines has made substantive progress,
as represented by the approval of five prophylactic vaccines since 2006. Generally, the …

Approximately 12% of human cancers worldwide are associated with infectious agents,
which are classified by the International Agency for Research on Cancer (IARC) as Group 1 …

The development of non-invasive mild photothermal therapy (MPTT) in combating
oropharyngeal carcinoma (OC) can bring safe and effective for patients, and keep maximum …

Human papilloma virus (HPV) infections vary in their oncogenic potential, and whether an
infection progresses to cervical intraepithelial neoplasia (CIN) also depends on the immune …

Cervical cancer (CaCx) is a major public health issue, with over 600,000 women diagnosed
annually. CaCx kills someone every 90 s, mostly in low-and middle-income countries. There …

Deletions of the GSTT1 and GSTM1 are associated with chemical carcinogenesis and
genitourinary malignancies like bladder cancer, where they correlate with increased tumor …

The Buschke–Löwenstein tumor (BLT), also known as giant condyloma acuminatum, is a
rare, exophytic tumor, arising from pre-existing warty lesions associated with human …

Background Herein, we evaluated the attributable fraction (AF) of human papillomavirus
(HPV)-mediated (HPV+) oropharyngeal carcinomas (OPCs) in Greece over a recent …

Introduction: The human papillomavirus (HPV) is the etiological agent of a variety of oral
mucosal benign and pre/malignant lesions, which demonstrate a wide range of prevalence …

Background Human papillomavirus (HPV) infection is an important factor leading to cervical
cell abnormalities. 90% of cervical cancers are closely associated with persistent infection of …